Search Results

Fred Hutchinson Cancer Center is an independent, nonprofit organization providing adult cancer treatment and groundbreaking research focused on cancer and infectious diseases. Based in Seattle, Fred Hutch is the only National Cancer Institute-designated cancer center in Washington. With a track record of global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy and COVID-19 vaccines, Fred Hutch has earned a reputation as one of the world’s leading cancer, infectious …

Fox Chase Cancer Center, Temple Health Researchers at Fox Chase Cancer Center have identified a genetic mechanism that can make small cell lung cancer tumors vulnerable to attack by the immune system. The discovery could be used to develop drugs that would make immunotherapy effective in small cell lung cancer for the first time. Read More

Stanford Cancer Institute Stanford Cancer Institute members Jennifer Caswell-Jin, MD, Sylvia Plevritis, PhD, and Allison Kurian, MD, MSc, are senior authors on an analysis published in the Journal of the American Medical Association finding that treatment of metastatic disease is responsible for nearly one-third of the decrease in annual deaths from breast cancer from 1975 to 2019. Read More

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University Care for patients with human papillomavirus-related squamous cell cancers of the oropharynx is shifting toward community cancer centers, but patients treated in this setting may be less likely to survive, according to new research by investigators from the Johns Hopkins Kimmel Cancer Center and its Head and Neck Cancer Center. Read More

LSU LCMC Health Cancer Center A research team from LSU LCMC Health Cancer Center has been awarded more than $1.5 million to eliminate barriers from cervical cancer prevention. The five-year program combines a $1.2 million grant from the American Cancer Society and an investment of $75,000 a year for five years from LSU Health New Orleans. Read More

The Tisch Cancer Institute at Mount Sinai Miriam Merad, MD, PhD, was elected as a Fellow of the American Association for Cancer Research (AACR) Academy, for her contributions in elucidating the roles of myeloid cells in inflammation and tumorigenesis and paving the way for the advancement of targeted therapies focusing on myeloid cells in both cancer and inflammatory diseases. Read More

UK Markey Cancer Center About 15 to 20 percent of women will develop an ovarian cyst during their lifetime. They are usually non-cancerous and about 85 percent resolve within five years. Recent UK Markey Cancer Center research reveals patient characteristics associated with cysts that resolve on their own and suggests that the time it takes can vary depending on several variables. The findings, published in Obstetrics & Gynecology, provide valuable guidance for doctors regarding how …

Sidney Kimmel Cancer Center at Jefferson Health Researchers at Sidney Kimmel Cancer Center at Jefferson Health (SKCC) are working to better understand neuroendocrine prostate cancer (NEPC), a particularly aggressive form of the disease that arises after the initial treatment of prostate cancer. The team was led by Lucia R. Languino, PhD, professor of cancer biology, director of the Genetics, Genomics, and Cancer Biology PhD program at Thomas Jefferson University, and member of SKCC’s Tra…

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute Digital pathology has both sped up and increased the accuracy of cancer diagnosis over the past 10 years, and now artificial intelligence (AI) could improve these tools even more. Most people think of AI as someone teaching a computer to recognize and respond to perform a specific task automatically (known as "supervised learning"); "unsupervised learning" involves teaching the com…

Roswell Park Comprehensive Cancer Center Following a national search, Roswell Park Comprehensive Cancer Center has selected George T. "Buddy" Hickman as its new chief digital & information officer. Hickman succeeds Tom Furlani, PhD, who retires this month. Hickman comes to Roswell Park with 30 years of experience in health care senior leadership. He was most recently with First Health Advisory, where he served as chief strategy officer. Read More

Huntsman Cancer Institute at the University of Utah Huntsman Cancer Institute and the University of Utah have named Umang Swami, MD, MS, and Matthew Covington, MD, as members of The Society of Huntsman Translational Scholars. This institutional initiative recognizes excellence in translational science and allows researchers to apply fundamental scientific findings to address clinical challenges in patient care. Read More

Duke Cancer Institute, Duke University Medical Center Duke Cancer Institute physician scientist Brent Hanks, MD, PhD, has been elected to the American Society for Clinical Investigation (ASCI), one of the nation's oldest medical honor societies. The ASCI supports the scientific efforts, educational needs, and clinical aspirations of physician-scientists to improve health. Read More

Vanderbilt-Ingram Cancer Center The American Urological Association has announced that Sam S. Chang, MD, MBA, is one of its 2024 award recipients who will be recognized at the organization’s annual meeting in May in San Antonio. He has been chosen for the Hugh Hampton Young Award, which is presented annually to an individual for outstanding contributions to the study of genitourinary tract diseases. Read More

Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine In a new study, researchers at Baylor College of Medicine and collaborating institutions report the development of a kinase inhibitor pulldown assay (KiP) that can optimally enrich and quantify the small amounts of kinases present in biopsy samples in combination with mass-spectrometry techniques. Read More

UCLA Jonsson Comprehensive Cancer Center UCLA Health has appointed leading breast surgical oncologist Mediget Teshome, MD, as the new chief of breast surgery and director of breast health. Before joining UCLA, Dr. Teshome was an associate professor at The University of Texas MD Anderson Cancer Center in the department of breast surgical oncology. Read More

Roswell Park Comprehensive Cancer Center In recognition of his dedication toward advancements in lung cancer care as well as his contributions as a valued mentor, Roswell Park Comprehensive Cancer Center chair of thoracic surgery, Sai Yendamuri, MD, MBA, FACS, has recently been honored with prestigious leadership roles, awards, and grant funding from both local and national organizations. Read More

University of Michigan Rogel Cancer Center Lori J. Pierce, MD, was one of 30 cancer scientists elected to the American Association for Cancer Research (AACR) class of Fellows of the AACR Academy. Dr. Pierce is professor of radiation oncology at Michigan Medicine and vice provost for academic and faculty affairs at the University of Michigan. Read More

University of Florida Health Cancer Center A new study led by a University of Florida College of Public Health and Health Professions researcher finds that people with chronic inflammation living in poverty have more than double the risk of dying from heart disease and nearly triple the risk of dying from cancer within the next 15 years. The findings are based on data representing 95 million Americans ages 40 and over. Read More

Hollings Cancer Center, Medical University of South Carolina Jezabel Rodriguez Blanco, PhD, who has a dual appointment at MUSC Hollings Cancer Center and the Darby Children’s Research Institute at MUSC, will receive $800,000 over four years from Alex’s Lemonade Stand Foundation for Childhood Cancer to continue her pursuit of the causes of medulloblastoma relapse. Read More

AACI members are invited to submit nominations for the 2024 Champion for Cures and Cancer Health Equity awards. The submission deadline for both awards is Monday, April 1. The awards will be presented during the 2024 AACI/CCAF Annual Meeting, October 20-22, at the Loews Chicago Hotel. Pictured: 2023 AACI Cancer Health Equity Award recipient Dr. Amelie Ramirez and AACI Executive Director Jennifer W. Pegher Read More

The Hollings Cancer Center (HCC) at the Medical University of South Carolina (MUSC) is the only National Cancer Institute (NCI)-designated Cancer Center in the State of South Carolina, serving 5.2M residents. As the only NCI-designated cancer center in South Carolina, HCC is part of an elite network of 72 cancer centers across the country recognized for our dedication to delivering cutting-edge treatments to patients and conducting innovative research to serve the unique needs of our state. HCC…

The LSU LCMC Health Cancer Center, located in New Orleans, LA, is seeking five faculty members at all academic levels who are committed to excellence in research that addresses biology and treatment of cancers that disproportionately burden the residents of Louisiana. Louisiana is at the heart of the US cancer burden with high incidence and mortality from most cancers, and faces significant challenges related to cancer care and health equity and disparities. However, for qualified, motivated, …

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute The OSUCCC – James, in collaboration with Nationwide Children’s Hospital, recently celebrated the opening of a $100 million, 55,000-square-foot Proton Therapy Center, the first treatment facility in central Ohio to offer this highly targeted radiation therapy for treating complex tumors. Read More

Association of American Cancer Institutes AACI invites you to promote your cancer center or business by purchasing an ad in the AACI Update. Your newsletter ad may highlight a conference or a new initiative. Supporters may include links to their website and any upcoming events. Ads can be purchased monthly or in one of several packages. Read More

Winship Cancer Institute of Emory University The American Association for Women in Radiology (AAWR) awarded the 2023 AAWR Marie Sklodowska-Curie Award to Winship Cancer Institute researcher Reshma Jagsi, MD, DPhil, Lawrence W. Davis professor and chair of radiation oncology at the Emory University School of Medicine. Read More

UMMC Cancer Center and Research Institute Rodney Rocconi, MD, director of the UMMC Cancer Center and Research Institute (CCRI), has been tasked with enhancing CCRI's mission of combating cancer through UMMC’s three-part mission of clinical care, research, and education. His first order of business: to begin the journey towards National Cancer Institute designation. Read More

VCU Massey Comprehensive Cancer Center The Robert A. Winn Diversity in Clinical Trials Award Program (Winn Awards) is designed to increase diversity in clinical trials and transform the clinical research landscape. Applications for one of the Winn Awards' signature programs, the Winn Career Development Award, are being accepted through Monday, May 13. Read More

Registration is open for the 16th Annual AACI Clinical Research Innovation (CRI) Meeting, which will be held June 24-26 at the Loews Chicago O'Hare Hotel in Rosemont, IL. The programming for this year's CRI meeting, "Compassion and Collaboration Through Clinical Trials," aims to stimulate cancer center interactions and maximize resources by creating opportunities for peer-to-peer networking and collaboration. Read More

UCSF Helen Diller Family Comprehensive Cancer Center Scientists at UC San Francisco and Northwestern Medicine, who are studying mutations in malignant T cells that cause lymphoma, have zeroed in on one that imparted exceptional potency to engineered T cells, which was able to kill solid tumors derived from skin, lung, and stomach tissues in mice. Read More

UK Markey Cancer Center More than 134,000 cancer cases went undiagnosed in the U.S. during the first 10 months of the COVID-19 pandemic, according to a new UK Markey Cancer Center study. The report provides the first estimates of missed cancer diagnoses in 2020 using nationwide surveillance data. Read More

UAMS Winthrop P. Rockefeller Cancer Institute The University of Arkansas for Medical Sciences (UAMS) met its $30 million fundraising goal for the Winthrop P. Rockefeller Cancer Institute’s campaign to achieve National Cancer Institute designation. The fundraising milestone was achieved with a $5 million gift from the Chris Fowler family. In total, 8,700 philanthropic gifts have been received from Arkansans and donors across the U.S. to support this campaign. Read More

Holden Comprehensive Cancer Center, University of Iowa UI Health Care is the first medical center in North America—and the second in the world—to cross over into the next phase of MR-Linac technology, offering even more precise real-time targeting of soft tissue tumors with radiation therapy. Read More

Fred Hutchinson Cancer Center Carl and Renée Behnke have donated $15 million to help launch a fundraising campaign and accelerate precision oncology research at Fred Hutchinson Cancer Center. In recognition of the gift, an 80-unit building that offers affordable short-term lodging to patients is being renamed the Behnke Family House. Read More

AACI's Physician Clinical Leadership Initiative (PCLI) will host a free webinar, titled “Not Your Typical Wellness Talk,” at 3:00 pm eastern time on Thursday, March 28. Webinar panelists are Quan Ly, MD, FACS, Fred & Pamela Buffett Cancer Center; Sarah Richards, MD, FACP, University of Nebraska Medical Center and Nebraska Medicine; and Steven Wengel, MD, University of Nebraska Medical Center. Read More

UCSF Helen Diller Family Comprehensive Cancer Center UC San Francisco is embarking on a bold initiative to catch cancer in its earliest forms and prevent it from progressing. Led by Margaret Tempero, MD, the new Cancer Early Detection and Interception initiative aims to detect and halt cancer before it takes root and spreads. Read More

A thought leader in the areas of workforce diversity and health equity, Karen Winkfield, MD, PhD, is the executive director of the Meharry-Vanderbilt Alliance, holds faculty positions at both Meharry Medical College and Vanderbilt University, and was appointed by President Joe Biden to the National Cancer Advisory Board in 2021. Dr. Winkfield will deliver the opening keynote at 8:00 am central time on Monday, March 12, during the 2024 AACI Leadership Diversity and Development Workshop. Read Mo…

University of New Mexico Comprehensive Cancer Center During the last days of January, which was Cervical Cancer Awareness month, Prajakta Adsul, MBBS, PhD, MPH, headed for Washington, DC, to participate in the inaugural White House Cervical Cancer Forum hosted by the Office of Science and Technology Policy, through the Biden Moonshot Initiative. Read More

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University A novel three-drug combination achieved notable responses in patients with advanced HER2-negative breast cancer, according to new research directed by investigators from the Johns Hopkins Kimmel Cancer Center. The treatment included a histone deacetylase inhibitor with two types of checkpoint inhibitors. Read More

The University of Chicago Medicine Comprehensive Cancer Center Kay Macleod, PhD, has been appointed as the associate director for basic sciences for the University of Chicago Medicine Comprehensive Cancer Center. The role was previously held for many years by Geoffrey Greene, PhD. Dr. Macleod is also a program co-leader of the center's Molecular Mechanisms of Cancer Research Program. Read More

The Operations Research Scientist position provides comprehensive technical expertise to the business unit specific operations data activities at Moffitt Cancer Center (“Moffitt”). This position works both collaboratively and independently under the direction of the Associate Center Director (ACD) of Research Diversity & Workforce Development (RDWD) to design agile quantitative and/or qualitative methodologies and to securely collect, analyze, store, quality control, visualize, and report p…

Are you looking for an opportunity to impact lives and be a central part of a dynamic and innovative team in the fight against cancer? As a Moffitt Clinical Research Coordinator, you’ll bring hope to patients by delivering tomorrow’s cancer treatments today! You will have the opportunity to interact directly with patients, enroll, educate and guide them through the experiences of taking part in clinical trials while receiving innovative treatments as part of a therapeutic clinical trial. You wi…

Nominations are being accepted for the annual Cancer Research Ally Award, which will be presented to one Democrat and one Republican member of Congress at a reception before the 2024 AACI/AACR Hill Day. AACI is also accepting nominations for Hill Day scholarship recipients. The scholarships enable patient advocates to attend the event and share their perspectives during congressional meetings. Read More

Vanderbilt-Ingram Cancer Center A multidisciplinary Vanderbilt research team has discovered a new way to kill a tumor by disrupting its acidic "microenvironment" without harming normal tissue. The target of this unorthodox approach is hydroxyapatite, a naturally occurring mineral that is a major component of bone and teeth, but which also is produced by some tumors. Read More

University of Florida Health Cancer Center A team of UF Health Cancer Center researchers have developed a first-of-its-kind compound that could open a new avenue for using immunotherapy to treat various types of cancer. Read More

University of Virginia Cancer Center University of Virginia Cancer Center researchers have developed a new way to identify high-risk patients with acute myeloid leukemia, which could one day lead to more tailored treatments and improved patient outcomes for patients with the blood cancer. Read More

Huntsman Cancer Institute at the University of Utah Huntsman Cancer Institute recently welcomed Katharine S. Ullman, PhD, into a new position of leadership. Dr. Ullman is celebrated for her advocacy in training and mentoring and dedication to learning. Read More

Laura and Isaac Perlmutter Cancer Center at NYU Langone Michelle Bloom, MD, has joined NYU Langone Health as system director of the Cardio-Oncology Program, which provides specialized care to protect patients’ heart health throughout cancer treatment and survivorship. Previously, Dr. Bloom served as co-director of the Cardio-Oncology Program at Stony Brook University Hospital. Read More

Duke Cancer Institute, Duke University Medical Center Ken H. Young, MD, PhD, and colleagues at Baylor College of Medicine and the University of Arkansas for Medical Sciences have identified mutational cancer drivers and microenvironment factors for the progression of myeloma and lymphoma and to generate effective agents for cancer prevention and treatment. Their work led to a National Cancer Institute grant totaling $4.65 million. Read More

The Tisch Cancer Institute at Mount Sinai Nina Bhardwaj, MD, PhD, is the recipient of a Cancer Research Institute (CRI)/Oliver R. Grace CLIP grant. Recognition of Dr. Bhardwaj as a Clinic and Laboratory Integration Program (CLIP) investigator distinguishes her as one of the CRI’s most promising scientists. Read More

Representatives Brian Fitzpatrick (R-PA), co-chair of the House Cancer Caucus, and Debbie Dingell (D-MI), jointly introduced the Knock Out (KO) Cancer Act for the 118th Congress in December 2023. This bipartisan legislation seeks to revolutionize cancer research funding by allocating a 25 percent increase to the National Cancer Institute's budget for the fiscal years 2024 through 2028. Write to your legislators today to urge them to support the KO Cancer Act. Read More

Huntsman Cancer Institute at the University of Utah Jonathan Constance, PhD, associate member in the Cell Response and Regulation Program at Huntsman Cancer Institute, is seeking to better understand how medications can be used more safely and effectively in different patient populations, especially pediatric cancer patients. Read More

Roswell Park Comprehensive Cancer Center A study led by scientists at Roswell Park Comprehensive Cancer Center details evidence on the therapeutic efficacy of a compound that targets a key genetic feature of pancreatic cancer. The work illustrates potential clinical applications for the novel anticancer agent MRTX1133 and outlines its effect on both the tumor and the surrounding environment. Read More

Cedars-Sinai Cancer To help protect the hearts of cancer patients, Cedars-Sinai investigators have created a three-dimensional "heart-on-a-chip" to evaluate chemotherapy and other cancer drug safety. In a new study, they show that the heart-on-a-chip, created using stem cells, accurately predicts the effects of drugs on human heart cells. Read More

Stanford Cancer Institute A study led by Stanford researchers found that an RNA-targeting CRISPR platform could tune immune cell metabolism without permanent genetic changes, potentially unveiling a relatively low-risk way to upgrade existing cell therapies for cancer. Read More

Rutgers Cancer Institute of New Jersey Rutgers Cancer Institute of New Jersey has modified its leadership structure, elevating two associate director functions to deputy director positions. Andrew M. Evens, DO, MBA, MSc, is deputy director for clinical services; Linda Tanzer is deputy director for administration and planning and chief financial and administrative officer; and Eileen White, PhD, will continue in the roles of deputy director and chief scientific officer. Read More

University of Michigan Rogel Cancer Center In a major advancement for cancer research at the University of Michigan, Mats Ljungman, PhD, has been awarded a $3.7 million grant from the National Institutes of Health. The funds will be used to build on Dr. Ljungman's innovative work in cancer therapy. Read More

UK Markey Cancer Center A new UK Markey Cancer Center study demonstrates a feasible way to expand germline genetic testing for patients with cancer. In the study, Markey's molecular tumor board reviewed germline research test results from a group of patients with various cancers. Findings were then communicated to patients' oncologists, along with recommendations for genetic counseling and confirmatory testing. Read More

The Tisch Cancer Institute at Mount Sinai Tisch Cancer Institute researchers discovered that a certain type of chemotherapy improves the immune system’s ability to fight off bladder cancer, particularly when combined with immunotherapy, according to a new study. Read More

City of Hope Comprehensive Cancer Center Newly published research demonstrates that older adults with blood cancers who receive reduced intensity chemotherapy before a stem cell transplant with donor cells that are resistant to HIV may be cured of HIV infection. Read More

UPMC Hillman Cancer Center Lymphatic fluid from surgical drains, which is usually tossed in the trash, is a treasure in the hands of University of Pittsburgh and Washington University School of Medicine in St. Louis researchers who found that this liquid could inform more precise treatments for patients with head and neck cancer caused by human papillomavirus. Read More

The University of Chicago Medicine Comprehensive Cancer Center A team of UChicago Medicine Comprehensive Cancer Center researchers have examined the contribution of biological, social, and economic factors on outcomes among adult patients with acute lymphoblastic leukemia (ALL). Their findings suggest that improved access to multidisciplinary medical care, coupled with essential supportive care services offered at centers experienced in ALL care, may alleviate socioeconomic disparities i…

UPMC Hillman Cancer Center Monica L. Baskin, PhD, has been appointed deputy director of UPMC Hillman Cancer Center where she will expand her efforts aimed at reducing health disparities, advancing the science of community outreach and engagement, and promoting representation in the workforce and clinical trials. Read More

Duke Cancer Institute, Duke University Medical Center Regardless of socioeconomic factors and tumor variables, Black women with triple negative breast cancer have a significantly poorer response to chemotherapy than white women, researchers at Duke Cancer Institute report. Read More

Roswell Park Comprehensive Cancer Center In work newly published in Blood Cancer Discovery, a journal of the American Association for Cancer Research, a team of collaborators from Roswell Park Comprehensive Cancer Center and Moffitt Cancer Center report the first strategy for identifying before treatment which patients are at risk for poor outcomes from CAR T-cell therapy, pointing to opportunities to improve the safety and efficacy of this fast-growing class of cancer immunotherapies. …

University of Michigan Rogel Cancer Center Using a chip to process blood samples, doctors can monitor the amount of cancer cells in a patient’s blood to determine how well a treatment is working by the fourth week, according to a new study by University of Michigan researchers. Read More

University of Florida Health Cancer Center University of Florida College of Pharmacy researchers have pinpointed the genetic blueprints behind dolastatin 10, a marine natural product that has led to six FDA-approved cancer drugs since 2011. The discovery could unlock the potential for new cancer therapeutics. Read More

Winship Cancer Institute of Emory University Curing Kids Cancer has awarded a $1.3 million gift to Winship Cancer Institute with $1 million to create an endowed professorship and $300,000 for immediate research funding. Kelly Goldsmith, MD, has been named the inaugural Curing Kids Cancer Professor of Pediatric Oncology. Read More

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University Older people may be at greater risk of developing pancreatic cancer and have poorer prognoses because of age-related changes in cells in the pancreas called fibroblasts, according to research by Johns Hopkins investigators. Read More

The University of Vermont Cancer Center and the Division of Hematology/Oncology, Department of Medicine in the Robert Larner, M.D. College of Medicine at the University of Vermont seeks a full time, research scholar pathway faculty member at the Assistant or Associate Professor level. Applicants must have a Ph.D. in Population Health, Public Health, Health Services Research or equivalent degree in related fields such as Epidemiology, Psychology, Sociology, or Data Science. Preference will be gi…

Comprehensive Cancer Center St. Jude Children's Research Hospital A recent study revealed two common biomarkers of cardiac function and damage that could better predict cardiomyopathy within five years compared to routine clinical exams in certain childhood cancer survivors. Utilizing these two biomarkers may lead to earlier treatment to prevent and protect against further heart damage. Read More

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute A kidney cancer clinical trial combined the experimental drug guadecitabine with the drug durvalumab, which works to stimulate the immune system. In phase Ib of the trial, scientists found this drug combination to be safe with tolerable side effects among six patients. Read More

Stanford Cancer Institute A Stanford-led study found that inosine supplementation in the CAR T-cell manufacturing process induced profound metabolic reprogramming, diminishing glycolysis, increasing mitochondrial and glycolytic capacity, glutaminolysis and polyamine synthesis; and reprogrammed the epigenome toward greater stemness. Read More

Winship Cancer Institute of Emory University Jessica Wells, PhD, FAAN, has been named assistant director for community outreach and engagement at Winship Cancer Institute. She is a fellow of the American Academy of Nursing and president-elect of the board of the National Association of Nurse Practitioners in Women’s Health. Read More

Laura and Isaac Perlmutter Cancer Center at NYU Langone Alexandra Miller, MD, PhD, has been named chief of the Neuro-Oncology Program and a co-director of the Brain and Spine Tumor Center at NYU Langone Health’s Perlmutter Cancer Center. She joins NYU Langone from Memorial Sloan Kettering Cancer Center. Read More

Cedars-Sinai Cancer The Department of Radiation Oncology at Cedars-Sinai Cancer has earned accreditation from the American Society for Radiation Oncology (ASTRO) Accreditation Program for Excellence. Read More

Rutgers Cancer Institute of New Jersey Bo (Bonnie) Qin, PhD, has received $1.1 million from the American Cancer Society to support her research on the impact of lifestyle patterns, social determinants of health, and inflammatory mechanisms on breast cancer survivorship among Black women. Read More

Join City of Hope's transformative team dedicated to fighting cancer and other illnesses. Our expanding national system includes the Los Angeles campus, clinical care locations across Southern California, a new cancer center in Orange County, California, and facilities in Atlanta, Chicago, and Phoenix. Our mission: deliver tomorrow's cures today. City of Hope Comprehensive Cancer Center (COHCCC) is among 55 U.S. cancer centers with a National Cancer Institute (NCI) designation, highlighting our…

Comprehensive Cancer Center St. Jude Children's Research Hospital St. Jude Children’s Research Hospital scientists improved chimeric antigen receptor (CAR) T–cell immunotherapy for acute myeloid leukemia (AML), demonstrating better efficacy in the lab. To overcome common problems with CAR T cells, the researchers created an additional means for the therapy to find and eliminate cancer cells, using a small peptide. Read More

Vanderbilt-Ingram Cancer Center A new study shows that oncogenic metabolic rewiring is an essential adaptation for the high energy demand of abnormal, dysplastic cells. In a mouse model, researchers introduced the KRAS oncogene in gastric chief cells to drive a sequential carcinogenic cascade of gastric cancer and identified the metabolic reprogramming that leads to dysplastic progression by turning on altered fatty acid metabolism. Read More

St. Jude Children's Research Hospital has an exciting new opportunity for a program coordinator in the HPV Cancer Prevention Program at St. Jude Children’s Research Hospital. We are seeking an individual who understands and shares the objectives of the organization and the impetus for this program focused on improving HPV vaccination and preventing HPV cancers in the St. Jude catchment area and beyond. The HPV Cancer Prevention Program offers ample opportunities for professional development and…

Fox Chase Cancer Center, Temple Health A team of nursing researchers from Fox Chase Cancer Center and Temple Health has received a $564,000 grant from the U.S. Department of Defense to fund research into increasing clinical trial enrollment of underrepresented kidney cancer patients by making it easier for them to participate in such trials. Read More

The Massey Cancer Center has an exciting opportunity for an CTO Assistant Director of Research Finance to join the team!  Our employees and applicants come from diverse backgrounds. We hire great people from a wide variety of backgrounds, not just because it’s the right thing to do, but because it makes VCU stronger. "To improve the lives of all Virginians by delivering cutting-edge cancer care through patient-centered prevention and treatment; high-impact, innovative research; community input…

Fred Hutchinson Cancer Center is an independent, nonprofit organization providing adult cancer treatment and groundbreaking research focused on cancer and infectious diseases. Based in Seattle, Fred Hutch is the only National Cancer Institute-designated cancer center in Washington. With a track record of global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy and COVID-19 vaccines, Fred Hutch has earned a reputation as one of the world’s leading cancer, infectious …

The University of Texas MD Anderson Cancer Center Giulio Draetta, MD, PhD, will serve as principal investigator (PI) of The University of Texas MD Anderson Cancer Center's Cancer Center Support Grant. Historically, MD Anderson’s president served as PI; however, this change addresses the demands of an increasingly complex organization and will optimize the institution’s programming and support for the grant. Read More

Huntsman Cancer Institute at the University of Utah Huntsman Cancer Institute (HCI) received $75 million from the Utah Legislature toward a cancer research and academic building in Utah County. This building is part of the first phase of HCI’s plan to establish a second comprehensive cancer center in Utah. Read More

After serving as director for more than 17 years, Brian Druker, MD (left), will take on a new role as the OHSU Knight Cancer Institute’s chief executive officer. In this newly created position, Dr. Druker will focus on long-term vision and strategic planning, fundraising, and donor engagement, as well as research and clinical growth. Before being recruited to Knight Cancer Institute in 2023, Tom Sellers, PhD, MPH (right), the institute's new director, served in key leadership roles at Mayo Clin…

Vanderbilt-Ingram Cancer Center Researchers at Vanderbilt University Medical Center, led by Jessica P. Miller, MD, PhD, are investigating whether sonograms of fallopian tubes can be effective for the early detection of ovarian cancer. Their findings support the use of fallopian tube luminal contrast enhancement during ultrasounds to detect abnormalities. Read More

Winship Cancer Institute of Emory University Lauren McCullough, PhD, MSPH, is part of an international team that was awarded a $25 million grant to help address cancer disparities in populations of African ancestry.   Read More

Cedars-Sinai Cancer In its latest global expansion, Cedars-Sinai International announced the opening of its new global office in Singapore. Cedars-Sinai representatives in Singapore will work with patients and their families seeking care at Cedars-Sinai in Los Angeles, offering access to Cedars-Sinai experts in cardiology, oncology, neurology, and other specialty areas. Read More

Siteman Cancer Center Siteman Cancer Center and Washington University School of Medicine have joined a new clinical trials network launched by the National Cancer Institute to investigate emerging technologies for cancer screening. They are among seven inaugural network members that will evaluate a blood test to detect multiple cancers. Aimee James, PhD, MPH, co-leads the Siteman-WashU effort. Read More

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University Combining the anticancer drugs enfortumab vedotin and pembrolizumab led to significantly improved survival rates among patients with advanced urothelial cancer compared with standard chemotherapy, according to results of a large international clinical trial involving 185 sites in 25 countries, including the Johns Hopkins Kimmel Cancer Center’s Greenberg Bladder Cancer Institute. Read More

Siteman Cancer Center An international team led by Yin Cao, ScD, MPH, a Washington University epidemiologist at Siteman Cancer Center, has received a five-year, $25 million grant to study the global increase in young-onset colorectal cancers. The team is funded by Cancer Research UK, the National Cancer Institute, the Bowelbabe Fund for Cancer Research UK, and Institut National Du Cancer in France, through Cancer Grand Challenges. Read More

Fred Hutchinson Cancer Center Fred Hutchinson Cancer Center is at the helm of a new clinical trials consortium, the Cancer Screening Research Network, or CSRN, created by the National Cancer Institute, part of the National Institutes of Health, to advance President Joe Biden’s Cancer Moonshot by improving early detection of cancers. Read More

Stanford Cancer Institute Soft tissue sarcomas are rare and difficult to treat. Machine-learning tools designed at Stanford Medicine uncover distinct cellular communities that correlate with prognosis, immunotherapy success. Read More

UAMS Winthrop P. Rockefeller Cancer Institute The University of Arkansas for Medical Sciences Winthrop P. Rockefeller Cancer Institute received a five-year, $11.48 million federal grant to create the Center for Molecular Interactions in Cancer. It will study the molecular features of biomolecules that drive cancer using structural biology and high-resolution imaging with precise, quantitative analysis.   Read More